Pediatric Sinusitis, Medical Treatment Treatment & Management

  • Author: Hassan H Ramadan, MD, MSc; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Apr 22, 2009
 

Medical Care

  • Antibiotic therapy for acute sinusitis
    • Indications are as follows:
      • Toxic child with suspected complications
      • Severe acute sinusitis
      • Persistent acute sinusitis
    • Because of the growing problem of bacterial resistance, do not administer antibiotics indiscriminately or without confirmation of history by physical examination.
    • Treat for 10-14 days or for 1 week beyond symptom resolution.
  • Adjunctive medical therapy for acute sinusitis
    • Saline sinus irrigation has demonstrated efficacy in the treatment of acute and chronic sinusitis. It increases mucociliary flow rates and aids in vasoconstriction. It mechanically clears secretions, decreases bacterial counts, and clears allergens and environmental irritants from the nose.
    • Nasal steroids are essential for patients with concurrent allergic rhinitis. Of patients with allergic rhinitis, 90% report improvement in symptoms, including nasal congestion.
      • Absorption through the nasal mucosa to the systemic system is minimal with most steroid preparations.
      • Adverse effects, including suppression of the pituitary axis and glaucoma, have been reported in adults.
      • Severe varicella infections have been reported in the pediatric population.
      • Few nasal steroids have been studied for their safety in young patients.
      • Carefully consider all choices.
    • Short bursts of systemic steroids can be helpful for patients with allergies. Many otolaryngologists also give patients with nasal polyposis a short burst before surgical intervention to decrease intraoperative blood loss.
    • Nasal decongestants are variably effective. Topical decongestants may improve patients' level of comfort. Restricting use to the first 4-5 days of medical treatment is best in order to avoid rebound vasodilatation.
    • Mucolytics are variably effective. No controlled studies have demonstrated efficacy.
    • Antihistamines are most useful in patients with atopy.
    • Immunotherapy is effective for patients with known specific allergies who have symptoms not responsive to other forms of traditional medical therapy.
  • Optimization of associated medical conditions
    • Allergic rhinitis: Measures include allergen avoidance, optimal environment, nasal steroids, a second-generation antihistamine, and possible immunotherapy.
    • Gastroesophageal reflux: Treat in consultation with a pediatrician or GI specialist. Conservative measures include elevating the head of the bed, not feeding immediately before bedtime, and thickening feeds. Medical therapy includes H-2 blockers, prokinetic agents, and hydrogen ion pump inhibitors.
    • Immune deficiency: Treat in consultation with an immunologist and possibly an infectious-disease specialist. Treatment involves aggressive routine medical therapy and possibly intravenous gamma-globulin injections. This is an expensive type of therapy with many possible associated complications.
    • Asthma: Measures include avoidance of exacerbating factors and use of bronchodilators and inhaled steroids.
    • Cystic fibrosis: Aggressive nasal toilet with saline irrigations, nasal steroids, and antibiotic irrigations for pseudomonad colonization may help optimize this condition, although antibiotic irrigations have never been prospectively studied effectively.
    • Immotile cilia syndromes: Mechanical clearance of secretions with daily irrigations is helpful in reducing the number of infections.
  • Chronic sinusitis
    • For patients with chronic rhinosinusitis, administer at least 4 weeks of a broad-spectrum beta-lactamase–resistant second-line antibiotic therapy.
    • Consider changing antibiotics if no significant response has occurred within 1 week. A culture may be required at that point to more appropriately adjust antibiotic coverage.
    • All of the above medical adjuncts may play a role, especially nasal steroids and saline irrigations.
    • Excluding or maximally treating all associated conditions is essential.
Next

Surgical Care

  • Adenoidectomy
    • A significant symptom overlap exists between adenoiditis and chronic sinusitis. The adenoids are niduses for infection and sources of obstruction.With adenoidectomy alone, symptom improvement occurs for more than 50% of patients.
    • Functional endoscopic sinus surgery
    • Consider surgery as a last resort in the pediatric population. An atraumatic technique with mucosal preservation is essential
  • Uncinate removal, anterior ethmoidectomy, and maxillary antrostomy are the most common forms of surgery. Second-look procedures to clean the cavity and remove crusts 2-3 weeks after surgery are not routinely needed. No data are currently available to support this as a necessary routine procedure.
    • Carefully consider risks of surgery and possible complications.
    • The overall success rate is approximately 80%. When combined with adenoidectomy at the same time, the rate can be higher.
    • Maxillary sinus wash and intravenous antibiotics have not been universally accepted.
    • Patients continue to require postoperative nasal toilet and treatment of associated conditions. This is especially true for patients with cystic fibrosis, in whom sinus surgery serves to open the sinuses more widely to aid in effective irrigation.
  • Balloon sinuplasty
    • This new procedure should be considered prior to endoscopic sinus surgery.
    • It is helpful for children, especially those children with minimal findings on CT scan but with significant symptoms and a failure to respond to continued medical therapy.
    • The procedure consists of dilating the ostia of the sinuses with a balloon instead of with the use of a sharp instrument.
    • Experience with this technique is still limited.
    • No long-term data on the patency of the ostia are yet available in children.
Previous
Next

Consultations

  • Ophthalmologist for orbital complications
  • Neurosurgeon for intracranial complications
  • Allergist for allergic rhinitis
  • Gastroenterologist for unmanageable GER
  • Immunologist for immune deficiencies
  • Pulmonologist for asthma or cystic fibrosis
Previous
Next

Diet

Patients with GER should eliminate caffeine, chocolate, and acidic beverages from their diets. Also, patients should not lie supine after meals, and no food should be consumed for 2 hours before bedtime. With food allergies, which are common in the pediatric population, appropriate restrictions are necessary.

Previous
Next

Activity

Tailor activity guidelines to the individual patient. Restrictions depend on the severity of illness and the patient's age. Patients with environmental allergies may require restrictions to avoid exposure to allergens. All patients with chronic sinusitis should be restricted from exposure to environmental irritants such as tobacco smoke.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Hassan H Ramadan, MD, MSc  Professor and Vice-Chair, Department of Otolaryngology-Head and Neck Surgery, Professor, Department of Pediatrics, West Virginia University

Hassan H Ramadan, MD, MSc is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Rhinologic Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Ted L Tewfik, MD, FRCS(C)  Professor, Department of Otolaryngology, Director of Continuing Medical Education of Otolaryngology, McGill University Medical School; Director, Director of Professional Affairs of Otolaryngology, Department of Otolaryngology, Montreal Children's Hospital; Senior Staff, Montreal General Hospital and Royal Victoria Hospital

Ted L Tewfik, MD, FRCS(C) is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Society of Pediatric Otolaryngology, Canadian Medical Association, Canadian Society of Otolaryngology-Head & Neck Surgery, Quebec Medical Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: Nothing to disclose.

Gregory C Allen, MD  Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Gregory C Allen, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Cleft Palate/Craniofacial Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Medical Association, Christian Medical & Dental Society, and Colorado Medical Society

Disclosure: Nothing to disclose.

Christopher L Slack, MD  Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation unstricted gift unknown

References

  1. Kay DJ, Rosenfeld RM. Quality of life for children with persistent sinonasal symptoms. Otolaryngol Head Neck Surg. Jan 2003;128(1):17-26. [Medline].

  2. Shin KS, Cho SH, Kim KR, et al. The role of adenoids in pediatric rhinosinusitis. Int J Pediatr Otorhinolaryngol. Nov 2008;72(11):1643-50. [Medline].

  3. Sivasli E, Sirikci A, Bayazyt YA, et al. Anatomic variations of the paranasal sinus area in pediatric patients with chronic sinusitis. Surg Radiol Anat. Feb 2003;24(6):400-5. [Medline].

  4. Bhattacharyya N, Jones DT, Hill M, Shapiro NL. The diagnostic accuracy of computed tomography in pediatric chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. Sep 2004;130(9):1029-32. [Medline].

  5. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. Aug 2008;122(2 Suppl):S1-84. [Medline].

  6. American Academy of Pediatrics, Subcommittee on Management of Sinusitis and Comm. Clinical practice guideline: management of sinusitis. Pediatrics. Sep 2001;108(3):798-808. [Medline].

  7. Anon JB. Acute bacterial rhinosinusitis in pediatric medicine: current issues in diagnosis and management. Paediatr Drugs. 2003;5 Suppl 1:25-33. [Medline].

  8. Barbero GJ. Gastroesophageal reflux and upper airway disease. Otolaryngol Clin North Am. Feb 1996;29(1):27-38. [Medline].

  9. Bothwell MR, Parsons DS, Talbot A, Barbero GJ, Wilder B. Outcome of reflux therapy on pediatric chronic sinusitis. Otolaryngol Head Neck Surg. Sep 1999;121(3):255-62. [Medline].

  10. Buchman CA, Yellon RF, Bluestone CD. Alternative to endoscopic sinus surgery in the management of pediatric chronic rhinosinusitis refractory to oral antimicrobial therapy. Otolaryngol Head Neck Surg. Feb 1999;120(2):219-24. [Medline].

  11. Clement PA, Bluestone CD, Gordts F, et al. Management of rhinosinusitis in children: consensus meeting, Brussels, Belgium, September 13, 1996. Arch Otolaryngol Head Neck Surg. Jan 1998;124(1):31-4. [Medline].

  12. Dohlman AW, Hemstreet MP, Odrezin GT, Bartolucci AA. Subacute sinusitis: are antimicrobials necessary?. J Allergy Clin Immunol. May 1993;91(5):1015-23. [Medline].

  13. Garbe E, LeLorier J, Boivin JF, Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA. Mar 5 1997;277(9):722-7. [Medline].

  14. Gilger MA. Pediatric otolaryngologic manifestations of gastroesophageal reflux disease. Curr Gastroenterol Rep. Jun 2003;5(3):247-52. [Medline].

  15. Goldsmith AJ, Rosenfeld RM. Treatment of pediatric sinusitis. Pediatr Clin North Am. Apr 2003;50(2):413-26. [Medline].

  16. Gross CW, Gurucharri MJ, Lazar RH, Long TE. Functional endonasal sinus surgery (FESS) in the pediatric age group. Laryngoscope. Mar 1989;99(3):272-5. [Medline].

  17. Gungor A, Corey JP. Pediatric sinusitis: a literature review with emphasis on the role of allergy. Otolaryngol Head Neck Surg. Jan 1997;116(1):4-15. [Medline].

  18. Gwaltney JM Jr. Combined antiviral and antimediator treatment of rhinovirus colds. J Infect Dis. Oct 1992;166(4):776-82. [Medline].

  19. Herrmann BW, Forsen JW Jr. Simultaneous intracranial and orbital complications of acute rhinosinusitis in children. Int J Pediatr Otorhinolaryngol. May 2004;68(5):619-25. [Medline].

  20. Kaliner MA, Osguthorpe JD, Fireman P, et al. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol. Jun 1997;99(6 Pt 3):S829-48. [Medline].

  21. Knutsson U, Stierna P, Marcus C, Carlstedt-Duke J, Carlstrom K, Bronnegard M. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol. Feb 1995;144(2):301-10. [Medline].

  22. Lesserson JA, Kieserman SP, Finn DG. The radiographic incidence of chronic sinus disease in the pediatric population. Laryngoscope. Feb 1994;104(2):159-66. [Medline].

  23. Mabry RL, Marple BF, Mabry CS. Outcomes after discontinuing immunotherapy for allergic fungal sinusitis. Otolaryngol Head Neck Surg. Jan 2000;122(1):104-6. [Medline].

  24. Mair EA, Bolger WE, Breisch EA. Sinus and facial growth after pediatric endoscopic sinus surgery. Arch Otolaryngol Head Neck Surg. May 1995;121(5):547-52. [Medline].

  25. Manning S. Surgical intervention for sinusitis in children. Curr Allergy Asthma Rep. May 2001;1(3):289-96. [Medline].

  26. Manning SC. Chronic sinusitis as a manifestation of primary immunodeficiency in adults. Am J Rhinol. 1994;8:29-34.

  27. Manning SC. Medical management of infectious and inflammatory disease. In: Cummings CW, et al, eds. Otolaryngology: Head and Neck Surgery. Vol 2. 3rd ed. St. Louis: Mosby; 1998:1135-1144.

  28. Manning SC. Paranasal sinus disease in children. Otolaryngol Head Neck Surg. 1993;171-176:1.

  29. McAlister WH, Lusk R, Muntz HR. Comparison of plain radiographs and coronal CT scans in infants and children with recurrent sinusitis. AJR Am J Roentgenol. Dec 1989;153(6):1259-64. [Medline].

  30. McCormick DP, John SD, Swischuk LE, Uchida T. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila). Sep 1996;35(9):457-60. [Medline].

  31. Meltzer EO. To use or not to use antihistamines in patients with asthma. Ann Allergy. Feb 1990;64(2 Pt 2):183-6. [Medline].

  32. Milczuk HA, Dalley RW, Wessbacher FW, Richardson MA. Nasal and paranasal sinus anomalies in children with chronic sinusitis. Laryngoscope. Mar 1993;103(3):247-52. [Medline].

  33. Muntz HR. Allergic fungal sinusitis in children. Otolaryngol Clin North Am. Feb 1996;29(1):185-22. [Medline].

  34. Parsons DS. Chronic sinusitis: a medical or surgical disease?. Otolaryngol Clin North Am. Feb 1996;29(1):1-9. [Medline].

  35. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. Jun 11 1987;316(24):1506-10. [Medline].

  36. Rosenfeld RM. Pilot study of outcomes in pediatric rhinosinusitis. Arch Otolaryngol Head Neck Surg. Jul 1995;121(7):729-36. [Medline].

  37. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope. Apr 2005;115(4):578-82. [Medline].

  38. Shapiro GG, Virant FS, Furukawa CT, Pierson WE, Bierman CW. Immunologic defects in patients with refractory sinusitis. Pediatrics. Mar 1991;87(3):311-6. [Medline].

  39. Tanner SB, Fowler KC. Intravenous antibiotics for chronic rhinosinusitis: are they effective?. Curr Opin Otolaryngol Head Neck Surg. Feb 2004;12(1):3-8. [Medline].

  40. Ungkanont K, Damrongsak S. Effect of adenoidectomy in children with complex problems of rhinosinusitis and associated diseases. Int J Pediatr Otorhinolaryngol. Apr 2004;68(4):447-51. [Medline].

  41. Vandenberg SJ, Heatley DG. Efficacy of adenoidectomy in relieving symptoms of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg. Jul 1997;123(7):675-8. [Medline].

  42. Vazquez E, Creixell S, Carreno JC, et al. Complicated acute pediatric bacterial sinusitis: Imaging updated approach. Curr Probl Diagn Radiol. May-Jun 2004;33(3):127-45. [Medline].

  43. Wolf G, Anderhuber W, Kuhn F. Development of the paranasal sinuses in children: implications for paranasal sinus surgery. Ann Otol Rhinol Laryngol. Sep 1993;102(9):705-11. [Medline].

 
Previous
Next
 
Preseptal cellulitis of the left eye. Courtesy of Dwight Jones, MD.
Axial CT scan of subperiosteal abscess of the left eye.
Coronal CT scan of subperiosteal abscess of the left eye.
Coronal CT scan of superior subperiosteal abscess of the left eye.
Axial CT scan of orbital cellulitis of the right eye.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.